Multimorbidity in elderly hospitalised patients and risk of Clostridium difficile infection: a retrospective study with the Cumulative Illness Rating Scale (CIRS)

BMJ Open. 2015 Oct 26;5(10):e009316. doi: 10.1136/bmjopen-2015-009316.

Abstract

Objectives: To identify the role of chronic comorbidities, considered together in a literature-validated index (Cumulative Illness Rating Scale, CIRS), and antibiotic or proton-pump inhibitor (PPI) treatments as risk factors for hospital-acquired Clostridium difficile infection (CDI) in elderly multimorbid hospitalised patients.

Design: Retrospective cohort study.

Setting: Subacute hospital geriatric care ward in Italy.

Participants: 505 (238 male (M), 268 female (F)) elderly (age≥65) multimorbid patients.

Main outcome measures: The relationship between CDI and CIRS Comorbidity Score, number of comorbidities, antibiotic, antifungal and PPI treatments, and length of hospital stay was assessed through age-adjusted and sex-adjusted and multivariate logistic regression models. The CIRS Comorbidity Score was handled after categorisation in quartiles.

Results: Mean age was 80.7±11.3 years. 43 patients (22 M, 21 F) developed CDI. The prevalence of CDI increased among quartiles of CIRS Comorbidity Score (3.9% first quartile vs 11.1% fourth quartile, age-adjusted and sex-adjusted p=0.03). In the multivariate logistic regression analysis, patients in the highest quartile of CIRS Comorbidity Score (≥17) carried a significantly higher risk of CDI (OR 5.07, 95% CI 1.28 to 20.14, p=0.02) than patients in the lowest quartile (<9). The only other variable significantly associated with CDI was antibiotic therapy (OR 2.62, 95% CI 1.21 to 5.66, p=0.01). PPI treatment was not associated with CDI.

Conclusions: Multimorbidity, measured through CIRS Comorbidity Score, is independently associated with the risk of CDI in a population of elderly patients with prolonged hospital stay.

Keywords: Antibiotic; Clostridium difficile; Elderly; Multimorbidity; Proton pump inhibitors.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Clostridium Infections / drug therapy*
  • Clostridium Infections / epidemiology*
  • Comorbidity
  • Cross Infection / drug therapy*
  • Cross Infection / epidemiology*
  • Female
  • Humans
  • Italy
  • Length of Stay*
  • Logistic Models
  • Male
  • Multivariate Analysis
  • Proton Pump Inhibitors / therapeutic use
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index

Substances

  • Anti-Bacterial Agents
  • Proton Pump Inhibitors